This document discusses several hot topics in digital health, including privacy laws like GDPR and CCPA, prescribing controlled substances via telemedicine, and the use of artificial intelligence in healthcare. It notes that Congress recently ordered action on prescribing controlled substances without an in-person evaluation. The document also provides examples of how AI is being used in telemedicine to analyze voice tones, images, and detect conditions. Finally, it outlines some legal issues that can arise from the use of AI in healthcare, such as intellectual property, privacy, reimbursement fraud, regulation, and liability.